Abstract:Synthetic challengesh ave significantly slowed the development of the catalytic asymmetrich ydroarsination reaction despite it being ah ighly attractive CÀAs bond formation methodology.Ina ddition, there is ap oor understanding of the main reactions teps in such reactions which limit further developmenti nt he field.H erein, key intermediates of the hydroarsination reactionc atalyzed by aP CP Ni II -Cl pincer complex are presentedu pon investigating the reactionw ith DFT calculations, conductivity measurements… Show more
“…The significant advances in main-group chemistry over the last few decades have prompted interest in the heavier pnictogen congeners and their corresponding hydropnictogenation reactions. − Compared to the abundance of HP reports, these heavier hydrofunctionalization endeavors are still in their infancy, and the very act of catalytic hydrobismuthation (unreported to our knowledge) would be a remarkable achievement. However, while we can make a direct link between HP and the potential for novel ligand design, a relationship to applications of the heavier homologues is less clear.…”
In this Perspective, we discuss what we perceive to be
the continued
challenges faced in catalytic hydrophosphination chemistry. Currently
the literature is dominated by catalysts, many of which are highly
effective, that generate the same phosphorus architectures, e.g.,
anti-Markovnikov products from the reaction of activated alkenes and
alkynes with diarylphosphines. We highlight the state of the art in
stereoselective hydrophosphination and the scope and limitations of
chemoselective hydrophosphination with primary phosphines and PH
3
. We also highlight the progress in the chemistry of the heavier
homologues. In general, we have tried to emphasize what is missing
from our hydrophosphination armament, with the aim of guiding future
research targets.
“…The significant advances in main-group chemistry over the last few decades have prompted interest in the heavier pnictogen congeners and their corresponding hydropnictogenation reactions. − Compared to the abundance of HP reports, these heavier hydrofunctionalization endeavors are still in their infancy, and the very act of catalytic hydrobismuthation (unreported to our knowledge) would be a remarkable achievement. However, while we can make a direct link between HP and the potential for novel ligand design, a relationship to applications of the heavier homologues is less clear.…”
In this Perspective, we discuss what we perceive to be
the continued
challenges faced in catalytic hydrophosphination chemistry. Currently
the literature is dominated by catalysts, many of which are highly
effective, that generate the same phosphorus architectures, e.g.,
anti-Markovnikov products from the reaction of activated alkenes and
alkynes with diarylphosphines. We highlight the state of the art in
stereoselective hydrophosphination and the scope and limitations of
chemoselective hydrophosphination with primary phosphines and PH
3
. We also highlight the progress in the chemistry of the heavier
homologues. In general, we have tried to emphasize what is missing
from our hydrophosphination armament, with the aim of guiding future
research targets.
“…However, a straightforward H/D isotope exchange was previously identified to occur for secondary arsines under neutral conditions (Scheme ). Consequently, >99% ortho-deuterated phosphine 1′ was isolated when HAsPh 2 was prestirred in MeOD (entry 4). Similarly, >99% ortho-deuterated phosphine 1′ was also obtained when DAsPh 2 (derived from prestirring HAsPh 2 in MeOD) was reacted with complex 1a in toluene (entry 5).…”
Secondary arsines were observed to decomplex strongly chelating phosphapalladacycles rapidly under mild conditions. As−H bond migration led to ortho-protonation of the C,P ligand. On the other hand, N−H and P−H bonds in amine and phosphine analogues were acidified under the same conditions and no ligand decomplexation of the metallacycle was observed. Subsequently, secondary arsines bearing the As−H bond were applied in deuteration by directed ortho-metalation (DoM) and decomplexation strategies. In the former, HAsPh 2 was a convenient deuterium shuttle which facilitated the orthodeuteration of DoM-palladacycle intermediates under neutral conditions. High deuterium incorporation (>99%) was achieved without specialized preformed deuterating agents. In the latter, HAsPh 2 afforded the preligands of monomeric, dimeric, bidentate, and tridentate complexes of Pd in excellent yields of 95−98% within 30 min at room temperature. Key reaction steps for the intramolecular insertion of As−H into the Pd−C bond were outlined, and the effects of regioisomerism on the orthoprotonation pathway were evaluated.
Potential widespread applications of organoarsenic chemistry have been limited by the inherent lack of safe and effective As−C bond formation reactions. Several alternative reagents and methods have been developed in the last few decades to address the hazards and drawbacks associated with traditional arsenic synthetic strategies. Herein, this minireview summarizes the advances made in nucleophilic, electrophilic, radical and metal‐mediated As(III)−C bond formations while specifically highlighting the behavior of arsenic synthons with various well‐established reagents (eg. Grignard reagents, organolithium compounds, organometallic reagents, radical initiators and Lewis/Brønsted bases). Avenues for asymmetric synthesis are also discussed, as are recent advances in organoarsenic chemistry suggesting that arsines exhibit novel reactivities independent from that of other relatively more well explored Group V cogeners.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.